Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01688557
Other study ID # Innovations in colonoscopy
Secondary ID
Status Completed
Phase N/A
First received September 16, 2012
Last updated October 6, 2016
Start date September 2012
Est. completion date September 2016

Study information

Verified date October 2016
Source Jagiellonian University
Contact n/a
Is FDA regulated No
Health authority Poland: Ministry of Health
Study type Interventional

Clinical Trial Summary

The trial will compare results of screening colonoscopy performed by means of conventional colonoscopy and using new visualisation techniques during endoscopic examination.

- Electronic colonoscopes Olympus CF-HQ190F with following options: magnetic positioning (Scope Guide), responsive insertion technology (RIT), dual focus function, narrow band imaging (NBI) will be used for innovative colonoscopies

- Electronic colonoscopes Olympus CF-H180DL with Scope Guide and NBI options will be used for conventional colonoscopies Endoscopists will archive all images and establish presumptive diagnosis based on the results of different visualisation techniques. All endoscopes will be attached to Olympus Evis Exera III system. Biopsy of all pathological lesions will be performed to establish final diagnosis. The main outcome measure is diagnostic accuracy of innovative colonoscopy in comparison with conventional technique.


Description:

A total of 600 consecutive patients undergoing screening unsedated colonoscopy will be randomly assigned to innovative or conventional examination. Randomization will be based on computer-generated randomization lists. All patients will be blinded so they will not know which techniques will be used to assess lesions found in colon. In innovative colonoscopy group narrow band imaging (NBI) and Dual Focus (DF) function will be used to identify and classify all lesions acc. to Sano and Kudo classification. Endoscopic biopsy will be taken from all lesion and endoscopic diagnosis will be compared with final histological diagnosis. Thus sensitivity, specificity, diagnostic accuracy, predictive values, likelihood ratio and Youden index will be calculated. As secondary endpoints total examination time, coecal intubation rate and pain intensity (VAS scale) will be established. This study will help to establish whether new technologies used during colonoscopy may improve diagnostic possibilities and whether they prolong examination time or lead to increase of pain intensity afterwards.


Recruitment information / eligibility

Status Completed
Enrollment 600
Est. completion date September 2016
Est. primary completion date September 2016
Accepts healthy volunteers No
Gender Both
Age group 40 Years to 65 Years
Eligibility Inclusion Criteria:

- written informed consent

- no previous abdominal surgery

- no colonoscopy during last 10 years

Exclusion Criteria:

- age < 40 and > 65 years

- large bowel resection in history

- colonoscopy performed during last 10 years

- contraindications for general anaesthesia

- ASA > IV

- pregnancy

- confirmed neoplastic disease

- cirrhosis (Child B or C) or ascites

- immunosuppressive therapy or steroids intake

- malabsorption syndrome

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Diagnostic


Intervention

Device:
Innovative colonoscopy (Olympus CF-HQ190F, NBI + Dual Focus)
NBI and Dual Focus options will be used to classify lesions according to Sano and Kudo classifications.
Conventional colonoscopy (Olympus CF-H180DL)
Conventional colonoscopy performed without innovative techniques used in experimental arm.

Locations

Country Name City State
Poland I Department of General Surgery, Jagiellonian University Krakow Malopolska
Poland Specialist Diagnostic and Therapeutic Center MEDICINA Krakow Malopolska

Sponsors (2)

Lead Sponsor Collaborator
Jagiellonian University Specialist Diagnostic and Therapeutic Center MEDICINA

Country where clinical trial is conducted

Poland, 

References & Publications (1)

Szura M, Pasternak A, Bucki K, Urbanczyk K, Matyja A. Two-stage optical system for colorectal polyp assessments. Surg Endosc. 2016 Jan;30(1):204-14. doi: 10.1007/s00464-015-4186-x. Epub 2015 Apr 4. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Sensitivity of innovative colonoscopy The sensitivity of innovative colonoscopy will be assessed (in percentages) using StatSoft Statistica 10.0 software. 1 year No
Other Specificity of innovative colonoscopy The specificity of innovative colonoscopy will be assessed (in percentages) using StatSoft Statistica 10.0 software. 1 year No
Other Positive predictive Value (PPV) od innovative colonoscopy The positive predicting value of innovative colonoscopy will be assessed using StatSoft Statistica 10.0 software. 1 year No
Other Negative predicting value (NPV) of innovative colonoscopy The negative predictive value (NPV) of innovative colonoscopy will be assessed using StatSoft Statistica 10.0 software. 1 year No
Other Youden's index for innovative colonoscopy The Youden's index of innovative colonoscopy will be assessed using StatSoft Statistica 10.0 software. 1 year No
Other Diagnostic odds ratio (DOR) for innovative colonoscopy The diagnostic odds ratio (DOR) of innovative colonoscopy will be assessed using StatSoft Statistica 10.0 software. 1 year No
Other Likelihood ratio for positive test results (LR+) The likelihood ratio for positive test results of innovative colonoscopy will be assessed using StatSoft Statistica 10.0 software. 1 year No
Other Likelihood ratio for negative test results (LR-) The likelihood ratio for negative test results (LR-) of innovative colonoscopy will be assessed using StatSoft Statistica 10.0 software. 1 year No
Other Area under the ROC curve (AUC) Area under the ROC curve for innovative colonoscopy will be calculated using StatSoft Statistica 10.0 software. 1 year No
Primary Diagnostic accuracy of innovative colonoscopy Diagnostic accuracy of innovative techniques used during colonoscopy (narrow band imaging and double focus option) will be assessed using StatSoft Statistica 10.0 software. All lesions will be classified acc. to Sano and Kudo classification during colonoscopy and results will be compared with histologic examination. 1 year No
Secondary Total examination time Time of the whole procedure (from insertion of the colonoscope to removing of the whole instrument) will be compared in conventional and innovative colonoscopy. 8-20 minutes No
Secondary Coecal intubation time Time from insertion of colonoscope to visualisation of the coecum - always confirmed by a snapshot. 5-15 minutes No
Secondary Pain intensity (VAS scale) Pain intensity will be assessed during and after each colonoscopy using the Visual Analogue Scale. It will be assessed immediately after colonoscopy, 15 min, 30 min, 1 hour and 2 hours after the procedure. 0-10 No
See also
  Status Clinical Trial Phase
Completed NCT03826043 - THrombo-Embolic Event in Onco-hematology N/A
Terminated NCT03166631 - A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread Phase 1
Completed NCT01938846 - BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors Phase 1
Recruiting NCT06058312 - Individual Food Preferences for the Mediterranean Diet in Cancer Patients N/A
Completed NCT03308942 - Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants Phase 2
Recruiting NCT06018311 - Exercising Together for Hispanic Prostate Cancer Survivor-Caregiver Dyads N/A
Withdrawn NCT05431439 - Omics of Cancer: OncoGenomics
Completed NCT01343043 - A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma Phase 1
Completed NCT01938638 - Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer Phase 1
Recruiting NCT05514444 - Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001) Phase 1
Recruiting NCT02292641 - Beyond TME Origins N/A
Terminated NCT00954512 - Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004) Phase 1/Phase 2
Recruiting NCT04958239 - A Study to Test Different Doses of BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) Phase 1
Recruiting NCT04627376 - Multimodal Program for Cancer Related Cachexia Prevention N/A
Completed NCT01222728 - Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients
Recruiting NCT06004440 - Real World Registry for Use of the Ion Endoluminal System
Active, not recruiting NCT05636696 - COMPANION: A Couple Intervention Targeting Cancer-related Fatigue N/A
Not yet recruiting NCT06035549 - Resilience in East Asian Immigrants for Advance Care Planning Discussions N/A
Recruiting NCT06004466 - Noninvasive Internal Jugular Venous Oximetry
Completed NCT02909348 - Immunophenotyping of Melanoma Patients on Treatment With Pembrolizumab